Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Silverman

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 30, 2011
Measuring health-related quality of life (HRQOL) in osteoporotic males using the Male OPAQS L Solimeo, S L Silverman, A D Calderon, et al.
Arthritis and Rheumatism|December 14, 2004
Association of severe vertebral fractures with reduced quality of life: reduction in the incidence of severe vertebral fractures by teriparatideG G Crans, S L Silverman, H K Genant, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 27, 2000
Deterioration in quality of life following hip fracture: a prospective studyA G Randell, T V Nguyen, N Bhalerao, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 16, 2009
Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppressionN Binkley, S L Silverman, C Simonelli, et al.
The Journal of Rheumatology|June 19, 1998
Quality of life in osteoporosis: reliability, consistency, and validity of the Osteoporosis Assessment QuestionnaireA G Randell, N Bhalerao, T V Nguyen, et al.
The Journal of Biological Chemistry|January 7, 1994
Identification of conserved amino acids in the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit critical for function. Evidence for formation of a heterodimeric receptor complex prior to ligand bindingL V Ronco, S L Silverman, S G Wong, et al.
Calcified Tissue International|August 1, 1993
Health-related quality of life in osteoporosis clinical trials. The Osteoporosis Quality of Life Study GroupG A Greendale, S L Silverman, R D Hays, et al.
Bone|January 27, 2009
Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: the eValuation of IBandronate Efficacy (VIBE) database fracture studyS T Harris, J-Y Reginster, C Harley, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 16, 2015
Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosisS L Silverman, A Wang, L Cheng, et al.
Aging (Milan, Italy)|February 1, 2002
Tolerability of risedronate in postmenopausal women intolerant of alendronateJ D Adachi, S Adami, P D Miller, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 30, 2011
Measuring health-related quality of life (HRQOL) in osteoporotic males using the Male OPAQS L Solimeo, S L Silverman, A D Calderon, et al.
Arthritis and Rheumatism|December 14, 2004
Association of severe vertebral fractures with reduced quality of life: reduction in the incidence of severe vertebral fractures by teriparatideG G Crans, S L Silverman, H K Genant, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 27, 2000
Deterioration in quality of life following hip fracture: a prospective studyA G Randell, T V Nguyen, N Bhalerao, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 16, 2009
Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppressionN Binkley, S L Silverman, C Simonelli, et al.
The Journal of Rheumatology|June 19, 1998
Quality of life in osteoporosis: reliability, consistency, and validity of the Osteoporosis Assessment QuestionnaireA G Randell, N Bhalerao, T V Nguyen, et al.
The Journal of Biological Chemistry|January 7, 1994
Identification of conserved amino acids in the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit critical for function. Evidence for formation of a heterodimeric receptor complex prior to ligand bindingL V Ronco, S L Silverman, S G Wong, et al.
Calcified Tissue International|August 1, 1993
Health-related quality of life in osteoporosis clinical trials. The Osteoporosis Quality of Life Study GroupG A Greendale, S L Silverman, R D Hays, et al.
Bone|January 27, 2009
Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: the eValuation of IBandronate Efficacy (VIBE) database fracture studyS T Harris, J-Y Reginster, C Harley, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 16, 2015
Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosisS L Silverman, A Wang, L Cheng, et al.
Aging (Milan, Italy)|February 1, 2002
Tolerability of risedronate in postmenopausal women intolerant of alendronateJ D Adachi, S Adami, P D Miller, et al.
Pageof 6